Login
$AGX
$340.83 +$11.49 (3.49%) Live

$AGX SEC Filings

Filed On Filing
23 Sep 2026 Form 4: Getsinger Peter W, Director

Received 895 shares by exercise or conversion ($35.9K)

11 Sep 2026 Form 4: Collins Charles Edwin Iv, CHIEF EXECUTIVE OFFICER, GEMMA

Granted 3,506 Time Based Restricted Stock Units

09 Sep 2026 8-K: Other Events

September 9, 2026 – ARLINGTON, VA – Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announces that its Board of Directors declared a 40% increase in the quarterly cash dividend, raising it from $0.50 to $0.70 per common share. T...

02 Sep 2026 10-Q
02 Sep 2026 8-K: Results of Operations and Financial Condition
04 Aug 2026 Form 4: Jeffrey John Ronald Jr., Director

Sold 5,716 shares ($3.31M)

04 Aug 2026 8-K: Other Events
31 Jul 2026 SCHEDULE 13G
31 Jul 2026 144
02 Jul 2026 Form 4: Jeffrey John Ronald Jr., Director

Received 5,716 shares by exercise or conversion ($212K)

23 Jun 2026 144/A
23 Jun 2026 Form 4: Griffin William F Jr, Director

Sold 30,000 shares ($21.8M) · Sold 20,000 shares ($15.2M)

22 Jun 2026 144
18 Jun 2026 Form 4: Baugher Joshua Scott, Chief Financial Officer

Received 455 shares by exercise or conversion ($27.9K) · Sold 760 shares ($557K)

18 Jun 2026 144
17 Jun 2026 Form 4: Sweeney Karen, Director

Sold 300 shares ($212K)

17 Jun 2026 Form 4: Getsinger Peter W, Director

Received 4,728 shares by exercise or conversion ($169K) · Sold 4,728 shares ($3.35M) · Sold 2,000 shares ($1.4M)

17 Jun 2026 144
17 Jun 2026 144
17 Jun 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support